Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 2/3 2Phase NA 1Phase 1 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Adenomatous Polyposis Coli 2Adenoma 2Polyps 1Neoplastic Syndromes, Hereditary 1Intestinal Neoplasms 1Intestinal Diseases 1Genetic Diseases, Inborn 1Gastrointestinal Neoplasms 1Gastrointestinal Diseases 1Duodenal Neoplasms 1Digestive System Neoplasms 1Digestive System Diseases 1Adenomatous Polyps 1

Interventions

Oxaliplatin 49Fluorouracil 46Capecitabine 41Cisplatin 36Gemcitabine 29Leucovorin 27Bevacizumab 21Drug Therapy 20Paclitaxel 15Folfox protocol 15Radiotherapy 14Irinotecan 14apatinib 11Neoadjuvant Therapy 11Docetaxel 11sintilimab 9S 1 (combination) 9Trastuzumab 8Sorafenib 8Nivolumab 8Surgical Procedures, Operative 7Magnetic Resonance Spectroscopy 7lenvatinib 6atezolizumab 6XELOX 6Cetuximab 6Albumin-Bound Paclitaxel 6130-nm albumin-bound paclitaxel 6tislelizumab 5pembrolizumab 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2/3 × Ursodeoxycholic Acid × Gastrointestinal × Clear all
NCT00808743 2013-05-16

PreDuoFAP

Radboud University Medical Center

Phase 2/3 Completed
37 enrolled
Gastrointestinal

Adenoma, Digestive System Diseases, Digestive System Neoplasms, Duodenal Neoplasms, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Intestinal Diseases, Intestinal Neoplasms, Neoplastic Syndromes, Hereditary, Adenomatous Polyposis Coli, Polyps, Adenomatous Polyps, Genetic Diseases, Inborn

NCT00134758 2009-07-29

Ursodeoxycholic Acid in the Treatment of Duodenal Adenomas in Familial Adenomatous Polyposis (FAP) Patients

Assistance Publique - Hôpitaux de Paris

Phase 2/3 Unknown
90 enrolled
Gastrointestinal

Adenoma, Adenomatous Polyposis Coli

Data powered by HemOnc (CC BY 4.0) Colophon âš¡